The American Society of Hematology (ASH) has announced the election of three new members to its Executive Committee, the governing body of the organization, for terms beginning after the 2015 ASH Annual Meeting, taking place December 5–8 in Orlando.
Alexis A. Thompson, MD, MPH, will serve a 1-year term as Vice President, followed by successive terms as President-Elect and President. Jane N. Winter, MD, and Steven L. Allen, MD, will each serve a 4-year term as Councillor.
Alexis A. Thompson, MD, MPH
Dr. Thompson is Head of the Hematology Section of the Division of Hematology Oncology Transplantation and Director of the Comprehensive Thalassemia Program at Ann and Robert H. Lurie Children’s Hospital of Chicago, where she also serves as the A. Watson and Sarah Armour Endowed Chair for Childhood Cancer and Blood Disorders. Dr. Thompson is also Associate Director of Equity and Minority Health at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
Dr. Thompson’s major fields of interest include sickle cell disease, thalassemia, transfusional iron overload, and stem cell transplantation for pediatric patients. In her position as Vice President, Dr. Thompson aims to enhance training programs to attract the next generation of scientists to hematology, as well as increase collaboration between ASH and global partners to improve hematology care and capacity around the world.
Dr. Thompson served as an ASH Councillor from 2010–2013 and is a member of the ASH Sickle Cell Task Force. She has served as a mentor for the Minority Medical Student Award Program for more than 10 years and is currently a reviewer for ASH’s journal, Blood.
Jane N. Winter, MD
Dr. Winter is Professor of Medicine in the Division of Hematology/Oncology at the Feinberg School of Medicine of Northwestern University in Chicago. She also serves as a member of the Robert H. Lurie Comprehensive Cancer Center.
Dr. Winter’s research interests include the clinical and biologic markers of prognosis in diffuse large B-cell lymphoma and clinical trials with novel agents in lymphoma.
An ASH member for more than 30 years, Dr. Winter has recently served as Chair of the Committee on Educational Affairs, as well as faculty for the ASH Clinical Research Training Institute and the ASH/European Hematology Association Translational Research Training in Hematology.
Steven L. Allen, MD
Dr. Allen is Associate Chief of Hematology at the Monter Cancer Center, North Shore-Long Island Jewish Health System in New Hyde Park, New York, and Professor of Medicine at Hofstra North Shore-Long Island Jewish School of Medicine in Hempstead, New York. Dr. Allen has maintained an active clinical practice and has been highly involved in the Society’s practice initiatives for more than 30 years. He currently serves as Chair of the Committee on Practice and is a participant in the ASH Practice Partnership program. Dr. Allen received the ASH Outstanding Service Award in 2006 for his leadership on the ASH Pay-for-Performance Task Force. ■
